Time-action profile of an inhaled insulin preparation in comparison to insulin lispro and regular insulin

被引:0
|
作者
Heise, T
Rave, K
Bott, S
Sha, S
Willavize, SA
Carroll, RS
Gruber, S
Lee, JD
Heinemann, L
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
39
引用
收藏
页码:A10 / A10
页数:1
相关论文
共 50 条
  • [1] Time-action profile of an inhaled insulin preparation in comparison to insulin Lispro and regular insulin
    Bott, S
    Heinemann, L
    Rave, K
    Sha, S
    Willavize, SA
    Carroll, RS
    Gruber, S
    Lee, JD
    Heise, T
    [J]. DIABETOLOGIA, 2000, 43 : A46 - A46
  • [2] Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin
    Rave, K
    Bott, S
    Heinemann, L
    Sha, S
    Becker, RHA
    Willavize, SA
    Heise, T
    [J]. DIABETES CARE, 2005, 28 (05) : 1077 - 1082
  • [3] Time-action profile of inhaled insulin
    Heise, T
    Traut, T
    Heinemann, L
    [J]. DIABETES, 1996, 45 : 819 - 819
  • [4] Time-action profile of inhaled insulin
    Heinemann, L
    Traut, T
    Heise, T
    [J]. DIABETOLOGIA, 1996, 39 : 89 - 89
  • [5] Time-action profile of inhaled insulin
    Heinemann, L
    Traut, T
    Heise, T
    [J]. DIABETIC MEDICINE, 1997, 14 (01) : 63 - 72
  • [6] Inhaled Technosphere/Insulin: Favourable time-action profile and low variability in comparison to subcutaneous human regular insulin
    Cheatham, WW
    Rave, K
    Boss, AH
    Heise, T
    [J]. DIABETOLOGIA, 2005, 48 : A30 - A30
  • [7] Time-action profile of insulin lispro and regular insulin in patients with type 1 diabetes and diabetic nephropathy
    Rave, R
    Sawicki, PT
    Heise, T
    Heinemann, L
    [J]. DIABETOLOGIA, 2000, 43 : A197 - A197
  • [8] Time-action profile of insulin glulisine (GLU) versus regular human insulin (RHI) and insulin lispro (IL) in obese subjects
    Frick, AD
    Burger, F
    Scholtz, H
    Becker, RHA
    [J]. DIABETES, 2004, 53 : A124 - A124
  • [9] The variability and time-action profile of inhaled Technosphere/Insulin compares favorably to that of subcutaneous human regular insulin
    Boss, AH
    Heise, T
    Rave, K
    Cheatham, WW
    [J]. DIABETES, 2005, 54 : A88 - A88
  • [10] Time-action profiles of premixed formulations of insulin lispro and NPL-insulin.
    Heise, T
    Weyer, C
    Serwas, A
    Heinrichs, S
    Osinga, J
    Roach, P
    Woodworth, J
    Heinemann, L
    [J]. DIABETES, 1997, 46 : 586 - 586